Cargando…

Application of Tumor Burden Score for predicting conversion outcome in patients with initially unresectable colorectal liver metastases after first-line systemic therapy

BACKGROUND: Patients with initially unresectable colorectal liver metastases (CRLM) could achieve survival benefit from successful conversion therapy. Recently, Tumor Burden Score (TBS) was proposed as a valuable index to predict outcome following resection of CRLM. The study is aimed to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Jianhong, Liu, Yujun, Li, Weihao, Lin, Yuzhu, Sun, Hui, Pan, Zhizhong, Wu, Xiaojun, Fan, Wenhua, Lin, Junzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721375/ https://www.ncbi.nlm.nih.gov/pubmed/34987612 http://dx.doi.org/10.1177/17562848211066206

Ejemplares similares

Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer
por: Peng, Jianhong, et al.
Publicado: (2021)

Neoadjuvant chemotherapy weakens the prognostic value of the pathological tumor burden score for colorectal cancer liver metastases
por: Liao, Leen, et al.
Publicado: (2023)

Conversion therapy with the intent to perform radical local treatment may not be suitable for patients with 10 or more liver metastases from colorectal cancer
por: Lin, Junzhong, et al.
Publicado: (2022)

Serum Gamma Glutamyl transferase is a predictor of recurrence after R0 hepatectomy for patients with colorectal cancer liver metastases
por: Xiao, Binyi, et al.
Publicado: (2020)

Surgical Options for Initially Unresectable Colorectal Liver Metastases
por: Popescu, Irinel, et al.
Publicado: (2012)

Does the Preoperative Prognostic Nutritional Index Predict Survival in Patients with Liver Metastases from Colorectal Cancer Who Underwent Curative Resection?
por: Zhao, Yujie, et al.
Publicado: (2018)

Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival
por: Peng, Jianhong, et al.
Publicado: (2017)

The Pathologic Complete Response Ratio of Liver Metastases Represents a Valuable Prognostic Indicator
por: Xu, Yanbo, et al.
Publicado: (2022)

Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer
por: Peng, Jianhong, et al.
Publicado: (2020)

Hepatitis B Virus Infection Predicts Better Survival In Patients With Colorectal Liver-only Metastases Undergoing Liver Resection
por: Zhao, Yujie, et al.
Publicado: (2018)

Efficacy and safety of a NiTi CAR 27 compression ring for end-to-end anastomosis compared with conventional staplers: A real-world analysis in Chinese colorectal cancer patients
por: Lu, Zhenhai, et al.
Publicado: (2016)

Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience
por: Peng, Jianhong, et al.
Publicado: (2019)

Surgical Outcomes of Robotic Resection for Sigmoid and Rectal Cancer: Analysis of 109 Patients From a Single Center in China
por: Peng, Jianhong, et al.
Publicado: (2021)

Prognostic value of tumor infiltrating lymphocytes combined with PD-L1 expression for patients with solitary colorectal cancer liver metastasis
por: Xiao, Binyi, et al.
Publicado: (2020)

Chemotherapy and target therapy as neo-adjuvant approach for initially unresectable colorectal liver metastases
por: Rossi, Luigi, et al.
Publicado: (2012)

How to increase the resectability of initially unresectable colorectal liver metastases: A surgical perspective
por: Imai, Katsunori, et al.
Publicado: (2019)

Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection?
por: Pan, Zhizhong, et al.
Publicado: (2018)

Conversion surgery for initially unresectable extrahepatic biliary tract cancer
por: Oh, Moon Young, et al.
Publicado: (2021)

Case report: Conversion therapy to permit resection of initially unresectable hepatocellular carcinoma
por: Chen, Kang, et al.
Publicado: (2022)

Efficacy of conversion therapy on initially unresectable locally advanced rectal cancer
por: Liu, Tianyu, et al.
Publicado: (2021)

Hepatectomy After Conversion Therapy for Initially Unresectable HCC: What is the Difference?
por: Luo, Laihui, et al.
Publicado: (2022)

Conversion Chemotherapy With a Modified FLOX Regimen for Borderline or Unresectable Liver Metastases From Colorectal Cancer: An Alternative for Limited-Resources Settings
por: Bonadio, Renata Colombo, et al.
Publicado: (2019)

BRAZILIAN CONSENSUS FOR MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 3: CONTROVERSIES AND UNRESECTABLE METASTASES
por: TORRES, Orlando Jorge Martins, et al.
Publicado: (2016)

Prognostic impact of acellular mucin pools towards the patients with locally advanced rectal cancer achieving pathological complete response after preoperative chemoradiotherapy
por: Zhang, Lin, et al.
Publicado: (2020)

Lymph node ratio as a valuable prognostic factor for patients with colorectal liver-only metastasis undergoing curative resection
por: Deng, Yuxiang, et al.
Publicado: (2018)

Downstaging Conversion Therapy in Patients With Initially Unresectable Advanced Hepatocellular Carcinoma: An Overview
por: Sun, Hui-Chuan, et al.
Publicado: (2021)

Impact of Upfront Chemotherapy on the Effect of Primary Tumour Resection for Asymptomatic Synchronous Colorectal Cancer With Unresectable Metastases: A Propensity-Score-Matched Cohort Analysis
por: Huang, Lin, et al.
Publicado: (2022)

Surgery in asymptomatic patients with colorectal cancer and unresectable liver metastases: the authors’ experience
por: Boselli, Carlo, et al.
Publicado: (2013)

Density of CD8+ lymphocytes in biopsy samples combined with the circulating lymphocyte ratio predicts pathologic complete response to chemoradiotherapy for rectal cancer
por: Xiao, Binyi, et al.
Publicado: (2017)

Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable
por: Ongaro, Elena, et al.
Publicado: (2019)

Partial response after treatment with Conversion chemotherapy: A case report of a patient with colon cancer and unresectable hepatic metastases
por: Bu, Zhaoting, et al.
Publicado: (2019)

Local surgical excision versus endoscopic resection for rectal carcinoid: A meta-analysis.
por: Sui, Qiaoqi, et al.
Publicado: (2017)

Metastatic Colorectal Cancer. First Line Therapy for Unresectable Disease
por: Aparicio, Jorge, et al.
Publicado: (2020)

Predictive And Prognostic Value Of Hepatic Steatosis In Conversion Therapy For Colorectal Liver-limited Metastases: A Propensity Score Matching Analysis
por: Jian, Mi, et al.
Publicado: (2019)

ASO Author Reflections: Towards Consensus on Resectability Assessments and Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases
por: Bond, Marinde J. G., et al.
Publicado: (2023)

Prognostic and predictive value of liver volume in colorectal cancer patients with unresectable liver metastases
por: Park, Jun Su, et al.
Publicado: (2014)

The Impact of Primary Tumor Resection on Survival in Asymptomatic Colorectal Cancer Patients With Unresectable Metastases
por: Doah, Ki Yoon, et al.
Publicado: (2021)

A contemporary systematic review on liver transplantation for unresectable liver metastases of colorectal cancer
por: Lebeck Lee, Cody M., et al.
Publicado: (2022)

FOLFOXIRI plus bevacizumab in the treatment of metastatic colorectal cancer patients with unresectable liver metastases
por: Antoniotti, Carlotta, et al.
Publicado: (2022)

Primary tumor resection in colorectal cancer patients with unresectable distant metastases: a minireview
por: Bai, Junge, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uouu6ea08qup963knlqc03r8iu